Indoco Board to meet May 7 for Q4/FY26 results & dividend

Indoco Remedies Ltd has announced that its Board of Directors will convene a meeting on Thursday, May 7, 2026. The primary agenda includes considering and approving the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. Additionally, the Board will consider recommending a final dividend for the financial year ending March 31, 2026, if applicable. The trading window for designated persons and their immediate relatives remains closed until May 9, 2026, which is 48 hours after the declaration of the financial results.